Diapharm herbal registrations for sale
Registrations for four new traditional herbal medicinal products for the treatment of sleep disturbances have just been granted to the German pharmaceutical service provider Diapharm by the UK's Medicines and Healthcare products Regulatory Agency (MHRA).
The registrations for DiaNight, DiaNight Plus, DiaSleep and DiaSleep Plus are to be offered for sale. DiaNight and DiaSleep are single-substance preparations in which one sugar-coated tablet contains 150mg of valerian root extract. DiaNight Plus and DiaSleep Plus are combination preparations, each sugar-coated tablet containing 125mg of valerian root extract and 250mg of passiflora extract. According to the MHRA, the products are indicated "for the temporary relief of sleep disturbances due to symptoms of mild anxiety, based on traditional use only."
Registration was granted on the basis of European Union Directive 2004/24/EC. Regulatory services for medicinal products are one of Diapharm's main areas of activity. In particular, the firm collaborates with manufacturers of traditional herbal medicinal products and more information on it is available at: www.diapharm.com.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze